A catalase nanocapsule inhibits VSMCs proliferation and migration through PTEN/NLRP3 pathway
Yudan Wang, Yu Chen, Wenjuan Quan, Taoli Sun, Zhe Shi, Qinhui Tuo · 2026
Read A catalase nanocapsule inhibits VSMCs proliferation and migration through PTEN/NLRP3 pathway by Yudan Wang, Yu Chen, Wenjuan Quan, Taoli Sun, Zhe Shi, Qinhui Tuo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194584.txt.
Description
Yudan Wang and five co-authors package the antioxidant enzyme catalase into a tiny capsule. The capsule calms the vessel-wall cells whose overgrowth narrows arteries. Smooth muscle cells that grow, move, and switch type drive vascular remodeling. Oxidative stress is a key trigger of that change. Free antioxidants fade too fast to help. So the capsule meters out steady scavenging of reactive oxygen species. The test used cells stimulated by angiotensin.
The nanocapsule lowered reactive oxygen in the cells. It held back cell growth and movement. It also restored the cells' contractile identity. It did so by reactivating PTEN and by damping the NLRP3 inflammasome pathway. When PTEN was blocked, the gains went away. That loss confirmed the axis at work. The authors propose the capsule as a nanotherapy candidate for oxidative vascular disease. More work would test it in whole animals next, past the dish.
Catalog record
| CREATOR | Yudan Wang, Yu Chen, Wenjuan Quan, Taoli Sun, Zhe Shi, Qinhui Tuo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |